How to Lead During Bioattacks with the Public - PowerPoint PPT Presentation

1 / 39
About This Presentation
Title:

How to Lead During Bioattacks with the Public

Description:

Global, round-the-clock news reports cause fear and dread and in places far from ... 7 Chicago-area residents died after taking Extra-Strength Tylenol capsules laced ... – PowerPoint PPT presentation

Number of Views:56
Avg rating:3.0/5.0
Slides: 40
Provided by: timho6
Category:

less

Transcript and Presenter's Notes

Title: How to Lead During Bioattacks with the Public


1
How to Lead During Bioattacks with the Publics
Trust and HelpA Manual for Mayors,
Governors,and Top Health Officials
  • UPMC CENTER FOR BIOSECURITY

2
Presentation Overview
3
Purpose Anticipate and Avert Governing Trouble
Spots that Arise during Epidemics
  • Set forth strategic goals that distinguish
    effective, compassionate leadership in epidemics
  • Illustrate circumstances posed by bioattacks that
    further complicate response to the health crisis
  • Identify dilemmas of governing that commonly
    arise during epidemics natural or
    deliberate
  • Recommend principles and actions for averting
    and/or remedying such predicaments

Presentation Overview
4
Working Group on Governance Dilemmas in
Bioterrorism Response
  • Convened by UPMC Biosecurity Center staff, Feb
    2003 to Feb 2004
  • Thirty members including seasoned political and
    public health decision-makers
  • Consensus statement Biosecurity Bioterrorism
    20042(1)25-40
  • Experience, professional judgment evidence
    obtained by literature review

Presentation Overview
5
What defines leadershipduring an epidemic
orbiological attack?
6
Dynamic Collaboration with the Public Essential
Means to Strategic Aims
  • Swifter resolution of immediate health crisis
  • Enhanced social and economic resilience of
    affected communities
  • Continuity of fundamental democratic values and
    processes

Successful Leadership Strategic Goals
7
Strategic Goals
  • Limit death and suffering through proper
    preventive, curative, and supportive care
  • Defend civil liberties by using least restrictive
    interventions to control spread of disease
  • Preserve economic stability, managing impact on
    victims and hard-hit locales
  • Discourage scapegoating and stigmatization
  • Bolster ability of individuals and groups to
    rebound from traumatic events

Successful Leadership Strategic Goals
8
Why do biological attackspresent special
challengesand high-stakes decisionsfor leaders?
9
Epidemics Are Complex Phenomena due to Unfolding
Biology and Competing Social Aims
  • Troubling to consider leaders and the public
    may deny problem or intervene too quickly without
    regard to negative effects.
  • People need to make sense of random and
    terrifying events, but epidemics elude quick and
    easy explanation.
  • Mysterious diseases can trigger impulse to
    isolate oneself and blame others, or to care for
    victims without regard to ones own safety.

Bioattacks Unique Challenges
10
Modern Conditions Disperse Impacts More Quickly,
Make Some People More Vulnerable
  • Global, round-the-clock news reports cause fear
    and dread and in places far from immediate harm.
  • Todays transportation moves people quickly
    across vast distances, potentially accelerating
    spread of disease.
  • Epidemics have broad, indirect financial impacts
    due to close ties among global, national, and
    local economies.
  • Poverty, lack of insurance, and distrust of
    healthcare system make those most vulnerable
    during outbreaks the least able to protect
    themselves.
  • Personnel shortages and lean budgets limit
    response capabilities of U.S. hospitals and
    health agencies.

Bioattacks Unique Challenges
11
Case Study SARS 2003
  • gt4,000 cases (1/2 total global count) traceable
    to chance encounter by handful of international
    travelers with virus at four-star Hong Kong
    hotel among the guests was an infected doctor
    who had treated patients in Guangdong Province,
    where the outbreak first emerged.
  • When the global SARS outbreak peaked, some New
    Yorkers transposed news reports on conditions in
    hard-hit cities like Hong Kong to their hometown,
    where impact was negligible.

Bioattacks Unique Challenges
12
Calculated Attack Further Magnifies the
Consequences of an Epidemic
  • Attackers motivations and tactics attacks on
    multiple cities or over a prolonged period
    heighten an epidemics uncertainties.
  • Scapegoating will be more severe than in natural
    outbreaks as people demand to know, Who did
    this?!
  • If a disease is weaponized or infects people
    through an unusual route (such as the mail), it
    may be harder to detect and treat.

Bioattacks Unique Challenges
13
Case Study Anthrax 2001
  • Frustration and confusion arose from lack of
    immediate answers to basic, factual questions.
    Who did this? How many letters were involved?
  • Health authorities and clinicians had to make
    critical decisions based on partial science What
    is best treatment? Who should receive antibiotics
    and for how long? Which mailrooms should be
    closed and surveyed?
  • Apparent gaps in the governments response
    fostered more uncertainty Were officials
    withholding information about the attack? Was
    treatment for postal workers and Capitol Hill
    employees really different, and why?

Bioattacks Unique Challenges
14
What leadership dilemmasmay arise in a
deliberate epidemic, and how mightthey be
averted?
15
Conflicts of Interest, Priority, and Purpose that
Commonly Emerge during Epidemics
  • Balancing imperatives of disease control with
  • Individual liberty
  • Economic stability
  • Protection against victim stigmatization

Epidemics Recurring Dilemmas
16
Stopping Disease that Spreads Person-to-Person
while Upholding Individual Freedoms
  • Make bioterrorism plans public before crisis
    occurs a well-informed population is more likely
    to follow advice.
  • Sketch out the big picture make concrete the
    fact that personal actions can affect the safety
    of others.
  • Provide goods and services that help people
    comply with health orders.
  • Use disease controls that respect autonomy and
    self-determination Public cooperation limits
    illness and death resistance does not.
  • Restrict civil liberties, if necessary, only in a
    transparent and equitable way.

Epidemics Recurring Dilemmas
17
Case Study Smallpox 1894
  • Facing a citywide outbreak, Milwaukee health
    authorities forcibly removed infected individuals
    to isolation hospitals, selectively using this
    technique among impoverished immigrants and not
    the well-off.
  • Perceived to be discriminatory and authoritarian,
    these measures caused month-long riots and
    ultimately abetted the spread of smallpox.
  • Outbreak Impact 1,079 cases, 244 deaths

Epidemics Recurring Dilemmas
18
Case Study Smallpox 1947
  • NYC officials effectively quelled outbreak by
    implementing a voluntary mass vaccination
    campaign that was universally applied, carrying
    out an elaborate public relations campaign, and
    involving grassroots organizations.
  • Outbreak impact 12 cases, 2 deaths

Epidemics Recurring Dilemmas
19
Protecting the Economy while Using Disease
Controls that Disrupt Commerce
  • Be mindful of the goal of long-term financial
    recovery when controlling disease do not react
    based solely on the desire to avert short-term
    economic loss.
  • Recognize public trust as precious capital that
    grows the economyif people see their health as
    your top priority, confidence in your efforts to
    safeguard the economy will follow.
  • Account for the less visible and more scattered
    monetary impacts when making epidemic control
    decisions (e.g., costs of victims healthcare,
    economic toll of stigma).

Epidemics Recurring Dilemmas
20
Case Study Tylenol 1982
  • 7 Chicago-area residents died after taking
    Extra-Strength Tylenol capsules laced with
    cyanide.
  • JJ executives halted manufacture, withdrew
    product worldwide, and offered customers refund
    or replacement.
  • 100 million in inventory was destroyed market
    share dropped 87 experts predicted the brands
    demise.
  • JJ reintroduced Tylenol products with
    tamper-resistant packaging, with robust
    advertising campaign.
  • Responding to the companys civic-minded
    behavior, consumer confidence rebounded, quickly
    returning market share to pre-crisis levels.

Epidemics Recurring Dilemmas
21
Restoring Social Bonds when People Feel at the
Mercy of a Mysterious Disease or Attacker
  • Express empathy for peoples fears about getting
    sick from others help people gauge personal risk
    accurately.
  • Explain to community-at-large the social costs of
    avoiding people out of fear, rather than out of
    actual danger.
  • Give frequent updates on the criminal
    investigation counsel people not to lash out
    against others.
  • Spotlight community projects aimed at bringing
    people together across social divisions
    sensitized by the crisis.
  • Direct law enforcement to deal appropriately with
    hate crimes in the event prevention fails.
  • Coordinate humanitarian relief effort, with extra
    focus on assisting the most vulnerable.

Epidemics Recurring Dilemmas
22
Case Study Anthrax 2001
  • Employees of American Media, Inc., the site of
    the first inhalational anthrax case, were doubly
    victimized.
  • Physically threatened by potential exposure to
    anthrax, they sometimes found themselves shunned
    by other community members.
  • Long-time physicians refused to care for them
    schools turned away their children and those
    moonlighting as housekeepers were not allowed
    into homes to clean.

Epidemics Recurring Dilemmas
23
What situations splinterthe social trust
necessaryto cope with health crises,and how
might theybe defused?
24
Alienation between Leaders and Public, and among
Community Members Themselves
  • Breaches in social trust are a common predicament
    during outbreaks and are likely to arise during a
    bioattack.
  • Often propelled by
  • Pre-existing social and economic fault lines
  • Preconceived notions about the government, the
    public, and the media

Social Trust Building Reserves
25
Unproductive Fear, Denial, or Skepticism by the
Public when Leaders Give Crisis Updates
  • Share what you know. Creative coping is the norm
    panic is the exception.
  • Hold press briefings early and often to reach the
    public.
  • Confirm that health agencies and medical
    facilities can handle onslaught of questions from
    concerned people.
  • Convey facts clearly and quickly so that people
    have peace of mind or so that they seek out care,
    if need be.
  • View rumors as a normal sign of the need to make
    sense of vague or disturbing events. Refine your
    outreach efforts the current ones may not be
    working.

Social Trust Building Reserves
26
Earning public confidence in leaders plans for
effective use of scarce resources
  • Account for income disparities in planning
    anticipate the need for free or low-cost
    prevention and treatment.
  • Make planning transparent so that the public sees
    that access to life-saving resources is based on
    medical need and not on wealth or favored status.
  • Be open about eligibility criteria for goods and
    services, especially when tough choices arise
    unexpectedly.
  • Show thorough preparations to protect vulnerable
    populations like children and the frail elderly,
    thus bolstering everyones sense of security.

Social Trust Building Reserves
27
Case Study Healthcare Access
  • Given routine differentials healthcare access and
    a prevalent belief that inequity will prevail
    during a bioattack, leaders are in the
    unfortunate position of having to prove
    otherwise.
  • One of every seven Americans lacks health
    insurance, with minorities overrepresented.
  • 72 of respondents to a Dec. 2002 national poll
    said they believed that if it were not possible
    to vaccinate everyone quickly during a smallpox
    outbreak in their community, wealthy and
    influential people would get the vaccine first.

Social Trust Building Reserves
28
Maintaining Credibility when Leaders Have to
Decide before All the Facts Are in
  • Advise the community at the outset if crisis
    conditions are evolving or could be prolonged.
  • Offer more detail rather than less, even when the
    unknowns outnumber what is known.
  • Resist the urge to reassure for reassurance sake
    alone.
  • Be frank about any uncertainty regarding facts
    describe plans to fill in knowledge gaps.
  • Vary your means of reaching the public. Mix
    high-tech outreach with contact through
    grassroots leaders.

Social Trust Building Reserves
29
Case Study Anthrax 2001
  • Secretary of Healths definitive reassurances
    that Bob Stevenss inhalational anthrax was an
    isolated case and that there is no terrorism
    came before all the facts were in.
  • Created the impression that the government was
    not forthcoming about the extent of the problem,
    especially when more cases of infection and
    anthrax-laden letters turned up.

Social Trust Building Reserves
30
Conclusion
31
Leadership Conscious Pursuit of Shared
Responsibility for the Publics Health
  • Approach the public as a capable ally
  • Keep planning and response transparent
  • Prioritize voluntary compliance among the many
    above coercion of the few
  • Advance equity in access to emergency resources
  • Share difficult decisions when they arise
  • Call for solidarity and compassion while
    shielding and aiding the ostracized

Conclusion
32
Acknowledgements
33
Veteran Politicaland Public Health Leaders
  • Georges Benjamin, MD, FACP, Exec Director,
    American Public Health Association Marylands
    Commissioner of Health during 01 anthrax attacks
  • William Bicknell, MD, MPH, Professor and Chairman
    Emeritus of International Health at Boston
    University, School of Public Health former
    Commissioner of Health for Massachusetts
  • Neal L. Cohen, MD, Executive Director, AMDeC
    Center on Bioterrorism former Commissioner of
    Health for New York City during 99 West Nile
    Virus outbreak, 01 World Trade Center bombing,
    and 01 anthrax attacks
  • Aaron Greenfield, JD, Executive Director,
    Maryland Business Council former Special City
    Solicitor Homeland Security Advisor, Baltimore
    City Mayors Office
  • Margaret A. Hamburg, MD, Vice President,
    Biological Programs, Nuclear Threat Initiative
    former Assistant Secretary for Planning
    Evaluation, Department of Health and Human
    Services
  • Jean Malecki, MD, MPH, FACPM, Director, Palm
    Beach County Health Department led investigation
    team of first inhalational anthrax case in 2001
  • Tara O'Toole, MD, MPH, Director, UPMC Center for
    Biosecurity former Director, Johns Hopkins
    Civilian Biodefense Center former Assistant
    Secretary of Energy for Environment, Safety and
    Health

Working Group
34
Medical, Public Health,and Disaster Experts
  • Kenneth D. Bloem, MPH, former top executive at
    Georgetown, Stanford, Chicago, and Boston
    University Medical Centers
  • Brian W. Flynn, EdD, Associate Director, Center
    for the Study of Traumatic Stress, Uniformed
    Services University former Rear
    Admiral/Assistant Surgeon General, U.S. Public
    Health Service
  • Thomas V. Inglesby, MD, Deputy Director, UPMC
    Center for Biosecurity former Deputy Director,
    Johns Hopkins Civilian Biodefense Center
    Infectious Disease Clinician, Johns Hopkins
    Hospital
  • Linda Morris, BSN, RN, Director, Community Health
    Youth, Greater Kansas City American Red Cross
    (GKC-ARC) former Community Health Nurse Manager,
    GKC-ARC
  • Ann E. Norwood, MD, COL MC, USA, Associate
    Professor Associate Chair, Department of
    Psychiatry, Uniformed Services University
  • Monica Schoch-Spana, PhD, Chair Senior Fellow,
    UPMC Center for Biosecurity former Senior
    Fellow, Johns Hopkins Civilian Biodefense Center
  • Kathleen Tierney, PhD, Director, Natural Hazards
    Research and Applications Center Professor of
    Sociology, University of Colorado at Boulder

Working Group
35
Community Leadersand Special Population Advocates
  • Naomi Baden, JD, MS, Facilitator, mediator,
    negotiator specializing in inter- and
    intra-organizational decision-making processes
  • Marion J. Balsam, MD, FAAP, Diplomate, American
    Board of Pediatrics Member, American Academy of
    Pediatrics Task Force on Terrorism retired Rear
    Admiral of Medical Corps of the U.S. Navy
  • Emira Habiby-Browne, MA, Founder Executive
    Director, Arab-American Family Support Center,
    New York City
  • Robert G. Kaplan, Founding Director, Commission
    of Intergroup Relations Community Concerns at
    the Jewish Community Relations Council of NY
    Public Health/Faith Based Community Institute of
    CDC and Emory Univ.
  • Myrna Lewis, PhD, Assistant Clinical Professor,
    Community Preventive Medicine, NYC Mount Sinai
    School of Medicine United Nations NGO Committees
    on Aging and Women NYC Mental Health Disaster
    Team
  • Onora Lien, Research Analyst, UPMC Center for
    Biosecurity Doctoral Candidate in Sociology,
    Johns Hopkins University
  • Shirley G. Mitchell, PhD, President, Board of
    Directors, Phyllis Wheatley YWCA, Washington, DC

Working Group
36
News Media, Public Affairs,and Risk
Communications Experts
  • Thom Berry, Director, Media Relations, South
    Carolina Dept of Health and Environmental
    Control Pres., National Public Health
    Information Coalition
  • John Burke, MA, JD, President, Strategic
    Communications Inc. Advisor to clients including
    Union Carbide, Pfizer, Merck, and Johnson
    Johnson
  • Joan Deppa, PhD, Associate Professor, S.I.
    Newhouse School of Communications, Syracuse
    University former UPI editor reporter
  • Darren Irby, Vice President of External Affairs,
    American Red Cross
  • Richard Knox, Health Science Correspondent,
    National Public Radio
  • Sandra Mullin, MSW, Director of Communications
    for NYC Health Department during 99 West Nile
    Virus outbreak, 01 World Trade Center attacks,
    01 anthrax attacks, and 03 SARS outbreak
  • Barbara Reynolds, MA, Crisis Emergency Risk
    Communication Specialist, CDC managed public
    communications during 01 anthrax attacks
  • Peter Sandman, PhD, Risk Communications
    Specialist advisor to NYC health department and
    CDC on bioterrorism, preparedness, and
    communication
  • Mary E. Walsh, National Security Producer, CBS
    News, assigned to Pentagon

Working Group
37
  • Support
  • Award MIPT-2002J-A-019 from the Oklahoma City
    Memorial Institute for the Prevention of
    Terrorism (MIPT) and the Office for Domestic
    Preparedness, Department of Homeland Security,
    and Award 2000-10-7 from The Alfred P. Sloan
    Foundation.
  • Disclaimer
  • Points of view in this presentation are those of
    the working group and do not necessarily
    represent the official position of MIPT, the U.S.
    Department of Homeland Security, or the Sloan
    Foundation.

38
Project Team
  • Monica Schoch-Spana, Principal Investigator
  • Bruce Campbell, Financial Administrator
  • Molly DEsopo, Production Coordinator
  • Jackie Fox, Senior Science Writer
  • Tim Holmes, Web Design Specialist
  • Onora Lien, Research Analyst
  • Scott Sugiuchi, Graphic Designer

Working Group
39
This presentation, additional materials, and
resources are available online at
  • www.upmc-biosecurity.org/pages/resources/leadershi
    p.html
Write a Comment
User Comments (0)
About PowerShow.com